Particle.news

Download on the App Store

Child Deaths From Toxic Cough Syrup Rise to 20 in India as WHO Seeks Export Details

Lab‑confirmed diethylene glycol in batch SR‑13 triggers wider bans, criminal probes, plus statewide testing.

Overview

  • Deputy Chief Minister Rajendra Shukla said 20 children have died in Madhya Pradesh (17 in Chhindwara, two in Betul, one in Pandhurna) with five more under treatment in Nagpur.
  • WHO asked India whether the implicated Coldrif syrup was exported and said it will assess issuing a Global Medical Products Alert once it receives official confirmation.
  • States including Tamil Nadu, Madhya Pradesh, Kerala, Karnataka, Punjab, Himachal Pradesh, Uttar Pradesh, Puducherry and Maharashtra restricted or banned Coldrif; Gujarat and other regulators flagged Relife and Respifresh TR for DEG above limits.
  • Tamil Nadu’s drug control issued a show‑cause notice to Sresan Pharmaceuticals, cited hundreds of GMP lapses, confirmed adulteration, halted production, and police teams moved to Kancheepuram to pursue the company owner.
  • The Union Health Ministry reported 19 samples collected with 10 detailed results so far (nine compliant, one failing) and launched risk‑based inspections; Madhya Pradesh formed an SIT, suspended officials, and arrested a prescribing doctor as the IMA objected to his detention.